Lifestyle behaviours and components of energy balance as independent predictors of ghrelin and adiponectin in young non-obese women

Diabetes and Metabolism

Volumn 32, Issue 2, 2006, Pages 131-139

  St Pierre, D H ^a   Faraj, M ^a   Karelis, A D ^a   Conus, F ^a   Henry, J F ^a   St Onge, M ^a   Tremblay Lebeau, A ^a   Cianflone, K ^b   Rabasa Lhoret, R ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Adipose tissue hormones; Energy balance; Gastrointestinal tract hormones

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; GHRELIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN;

ACCELEROMETER; ADULT; APPETITE; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CALORIC INTAKE; CALORIMETRY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; EATING HABIT; ENERGY BALANCE; ENERGY EXPENDITURE; FEEDING BEHAVIOR; FEMALE; FITNESS; FOOD INTAKE; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; LIFESTYLE; METABOLIC RATE; NORMAL HUMAN; OBESITY; OXYGEN CONSUMPTION; PHYSICAL ACTIVITY; PREDICTION; QUESTIONNAIRE; REGULATORY MECHANISM; WAIST CIRCUMFERENCE;

EID: 33645981288     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70259-8     Document Type: Article

References (54)

1. Kojima M, Hosoda H, Date Y, Nakanzato M, Matsuo H, Kangawa K. Ghrelin is a growth-horome-releasing acylated peptide from stomach. Nature 1999;402:656-60
2. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000;407:908-13
3. Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001;86:5992
4. Asakawa A, Inui A, Kaga T, et al. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 2001;120:337-45
5. Wren AM, Small CJ, Abbott CR, et al. Ghrelin causes hyperphagia and obesity in rats. Diabetes 2001;50:2540-7
6. Shiiya T, Nakazato M, Mizuta M, et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 2002;87:240-4
7. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001;50:707-9
8. Fruhbeck G, Gomez-Ambrosi J, Muruzabal FJ, Burrell MA. The Adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endo Metab 2001;280:E827-E847
9. Stephens TW, Basinski M, Bristow PK, et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995;377:530-2
10. Tang-Christensen M, Havel PJ, Jacobs RR, Larsen PJ, Cameron JL. Central administration of leptin inhibits food intake and activates the sympathetic nervous system in Rhesus Macaques. J Clin Endocrinol Metab 1999;84:711-7
11. Farooqi IS, Jebb SA, Langmack G, et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Eng J Med 1999;341:879-84
12. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995;269:546-9
13. Faraj M, Lu HL, Cianflone K. Diabetes, lipids, and adipocyte secretagogues. Biochem Cell Biol 2004;82:170-90
14. van Dielen FM, van't Veer C, Buurman WA, Greve JW. Leptin and soluble leptin receptor levels in obese and weight-losing individuals. J Clin Endocrinol Metab 2002;87:1708-16
15. Ren J. Leptin and hyperleptinemia - from friend to foe for cardiovascular function. J Endocrinol 2004;181:1-10
16. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83
17. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995;270:26746-9
18. Statnick MA, Beavers LS, Conner LJ, et al. Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes. Int J Exp Diab Res 2000;1:81-8
19. Stefan N, Vozarova B, Funahashi T, et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 2002;51:1884-8
20. Pajvani UB, Scherer PE. Adiponectin: systemic contributor to insulin sensitivity. Current Diabetes Rep 2003;3:207-13
21. Matsubara M, Maruoka S, Katayose S. Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 2002;87:2764-9
22. Ouchi N, Kihara S, Arita Y, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 2000;102:1296-301
23. Ouchi N, Kihara S, Arita Y, et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001;103:1057-63
24. Pistola T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB. Plasma adiponectin levels and risk of myocardial infarction in men. J Am Med Assoc 2004;291:1730-7
25. Diamanti-Kandarakis E, Baillargeon JP, Iuorno MJ, Jakubowicz DJ, Nestler JE. A modern medical quandary: polycystic ovary syndrome, insulin resistance, and oral contraceptive pills. J Clin Endocrinol Metab 2003;88:1927-32
26. Nemet D, Wang P, Funahashi T, et al. Adipocytokines, body composition, and fitness in children. Pediatr Res 2003;53:148-52
27. Schectman G, Patsches M, Sasse EA. Variability in cholesterol measurements: comparison of calculated and direct LDL cholesterol determinations. Clin Chem 1996;42:732-7
28. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9
29. Canada H. Canadian Nutrient File. Ottawa, Ontario, Canada: Health Canada, 2001
30. Stunkard AJ, Messick S. The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Phychosom Res 1985;29:71-83
31. Laessle RG, Tuschl RJ, Kotthaus BC, Pirke KM. A comparison of the validity of three scales for the assessment of dietary restraint. J Abnorm Psychol 1989;98:504-7
32. Cunningham JJ. Calculation of energy expenditure from indirect calorimetry: assessment of the Weir equation. Nutrition 1990;6:222-3
33. Westerterp KR. Physical activity assessment with accelerometers. Int J Obesity Rel Metab Dis 1999;23:S45-S49
34. Nichols JF, Morgan CG, Sarkin JA, Sallis JF, Calfas KJ. Validity, reliability, and calibration of the Tritrac accelerometer as a measure of physical activity. Medicine and Science in Sports and Exercise 1999;31:908-12
35. St Pierre DH, Karelis AD, Cianflone K, et al. Relationship between ghrelin and energy expenditure in healthy young women. J Clin Endocrinol Metab 2004;89:5993-7
36. Filate WA, Johansen HL, Kennedy CC, Tu JV. Regional variations in cardiovascular mortality in Canada. Can J Cardiol 2003;19:1241-8
37. Cummings DE, Clement K, Purnell JQ, et al. Elevated plasma ghrelin levels in Prader Willi syndrome. Nat Med 2002;8:643-4
38. Saad MF, Bernaba B, Hwu CM, et al. Insulin regulates plasma ghrelin concentration. J Clin Endocrinol Metab 2002;87:3997-4000
39. Speakman JR, Selman C. Physical activity and resting metabolic rate. Proc Nutr Soc 2003;62:621-34
40. Foster-Schubert KE, McTiernan A, Frayo RS, et al. Human plasma ghrelin levels increase during a one-year exercise program. J Clin Endocrinol Metab 2005;90:820-5
41. Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Eng J Med 2002;346:1623-30
42. Hansen TK, Dall R, Hosoda H, et al. Weight loss increases circulating levels of ghrelin in human obesity. Clin Endocrinol (Oxf) 2002;56:203-6
43. Faraj M, Havel PJ, Phelis S, Blank D, Sniderman AD, Cianflone K. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 2003;88:1594-602
44. Purnell JQ, Weigle DS, Breen P, Cummings DE. Ghrelin levels correlate with insulin levels, insulin resistance, and high-density lipoprotein cholesterol, but not with gender, menopausal status, or cortisol levels in humans. J Clin Endocrinol Metab 2003;88:5747-52
45. Beaumont NJ, Skinner VO, Tan TMM, et al. Ghrelin can bind to a species of high density lipoprotein associated with paraoxonase. J Biol Chem 2003;278:8877-80
46. Poobalan A, Aucott L, Smith WCS, et al. Effects of weight loss in overweight/obese individuals and long-term lipid outcomes - a systematic review. Obesity Reviews 2004;5:43-50
47. Halaas JL, Gajiwala KS, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995;269:543-6
48. Kamohara S, Burcelin R, Halaas JL, Friedman JM, Charron MJ. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 1997;389:374-7
49. Ceddia RB, William WN, Jr., Lima FB, Curi R. Leptin inhibits insulin-stimulated incorporation of glucose into lipids and stimulates glucose decarboxylation in isolated rat adipocytes. J Endocrinol 1998;158:R7-R9
50. Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV. Leptin: the tale of an obesity gene. Diabetes 1996;45:1455-62
51. Lindsay RS, Funahashi T, Hanson RL, et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002;360:57-8
52. Pellme F, Smith U, Funahashi T, et al. Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients. Diabetes 2003;52:1182-6
53. Cruz M, Garcia-Macedo R, Garcia-Valerio Y, et al. Low adiponectin levels predict type 2 diabetes in Mexican children. Diabetes Care 2004;27:1451-3
54. Tran KM, Johnson RK, Soultanakis RP, Matthews DE. In-person vs telephone-administered multiple-pass 24-hour recalls in women: validation with doubly labeled water. J Am Diet Assoc 2000;100:777-83